Sinués, B., Gazulla, J., Bernal, M., Lanuza, J., Fanlo, A., Saenz, M., & Bartolome, M. (1995). Six mutagenicity assays in exposure biomonitoring of patients receiving carbamazepine for epilepsy or trigeminal neuralgia. Mutation Research, 334(2), 259-265. https://doi.org/10.1016/0165-1161(95)90019-5
Chicago Style (17th ed.) CitationSinués, B., J. Gazulla, M.L Bernal, J. Lanuza, A. Fanlo, M.A Saenz, and M. Bartolome. "Six Mutagenicity Assays in Exposure Biomonitoring of Patients Receiving Carbamazepine for Epilepsy or Trigeminal Neuralgia." Mutation Research 334, no. 2 (1995): 259-265. https://doi.org/10.1016/0165-1161(95)90019-5.
MLA (9th ed.) CitationSinués, B., et al. "Six Mutagenicity Assays in Exposure Biomonitoring of Patients Receiving Carbamazepine for Epilepsy or Trigeminal Neuralgia." Mutation Research, vol. 334, no. 2, 1995, pp. 259-265, https://doi.org/10.1016/0165-1161(95)90019-5.